China Respiratory Care Devices Market Overview, 2031

The Chinese market for respiratory devices, which includes ventilators, CPAP/BiPAP machines, oxygen concentrators, nebulizers, and associated technologies, has swiftly progressed within China. This growth has been spurred by an increase in respiratory illnesses related to air pollution, an aging population, and lifestyle choices such as smoking. The market for respiratory care devices is expected to experience considerable growth. This trend is fueled by a strong demand for devices used in hospitals and home settings. China reflects a similar trend, seeing rapid market growth as pollution and chronic respiratory diseases such as COPD, asthma, and sleep apnea rise, thereby boosting the need for diagnostic, therapeutic, and supportive respiratory devices. The adoption of new technology has been a crucial factor in this transformation. Enhanced sensor technologies, AI-based adaptive ventilation systems, and remote connectivity for real-time patient assessment are increasingly integrated into various device categories, enhancing personalization and clinical results. Telehealth services and remote diagnostics offer scalable and decentralized care, essential for areas with limited healthcare resources. The fast growth of research and development is visible in the prevalence of intelligent, data-enabled devices. Key industry players are making substantial investments in digital advancements to remain competitive and tackle complex respiratory issues early on. Regulatory oversight, particularly in China, has influenced market trends. The National Medical Products Administration NMPA oversees approval and classification for medical devices, with Class II/III respiratory products needing thorough registration, technical documentation, and clinical assessments to guarantee safety and effectiveness. The NMPA's recent updates emphasize quicker review processes for innovative technologies and ongoing quality management, promoting local innovation while aiding international companies in meeting regulatory standards without compromising safety.

According to the research report, " China Respiratory Devices Market Overview, 2031," published by Bonafide Research, the China Respiratory Devices market is anticipated to grow at more than 7.67% CAGR from 2026 to 2031. Rapid growth has been seen in China's respiratory devices sector, fueled by increased healthcare expenditure, a higher rate of respiratory issues due to pollution and aging populations, and a drive for domestic innovation. Estimates reveal that the wider respiratory device market in China, which includes ventilators, home oxygen supplies, and devices for treating sleep apnea, is significantly expanding, with market values reaching hundreds of billions of RMB and projections indicating continued robust growth into the next decade. Recent advancements are reshaping the field. Intelligent respiratory tools featuring telehealth connections, Internet of Things sensor data, and cloud-based analysis enhance the management of ailments and boost patient compliance. Ventilation support systems aided by AI and dynamic CPAP machines provide individualized care by evaluating diverse patient data in real time. Portable and wearable respiratory technology is also gaining popularity, fulfilling needs in home health care and chronic illness management with improved accessibility and reduced healthcare expenses. Support from the NMPA opens doors for both general and specialized devices. The NMPA’s structured classification and review process which includes fast-track options for new technologies and strict criteria for high-risk devices encourages innovation while upholding safety standards. For local manufacturers, complying with NMPA rules, improving quality management systems, and speeding up clinical validation assist in reducing time to market and gaining a competitive edge.

In China, the classification by product type including therapeutic devices, monitoring devices, diagnostic devices, and consumables & accessories showcases the varied requirements for respiratory care in both clinical and domestic environments, influenced by a high incidence of respiratory diseases and growing health consciousness. Therapeutic devices dominate this market segment because they play a crucial role in managing chronic and acute respiratory illnesses like chronic obstructive pulmonary disease COPD, asthma, sleep apnea, pneumonia, and acute respiratory distress. Equipment such as ventilators, oxygen concentrators, CPAP/BiPAP machines, and nebulizers are commonly utilized in hospitals and are becoming more prevalent in-home care settings to facilitate long-term treatments and manage emergencies. The therapeutic sector in China was valued at hundreds of millions in USD and is predicted to experience double-digit growth in several subcategories in response to increasing demand from both urgent care and the aging demographic. Monitoring devices which consist of pulse oximeters, capnographs, and spirometers are gaining popularity as China adopts digital health initiatives and remote patient oversight. These devices, motivated by clinical needs and the move towards home-based healthcare, enable real-time respiratory function assessments, allowing for early identification of disease flare-ups and enhancing management of chronic conditions. A growing trend involves their integration with mobile applications and cloud technologies, especially for spirometry and oximetry devices used in community health initiatives. Diagnostic devices are becoming more vital as China prioritizes early detection of illnesses. Tools like peak flow meters and advanced imaging equipment support the diagnosis of asthma, COPD, and infectious respiratory issues. This diagnostic category is among the fastest growing, fueled by increased laboratory capabilities and the rise of molecular testing approaches.

China Respiratory Devices market by end user is divided into hospitals, ambulatory care centers, home care settings and other user. In China, the respiratory devices market is divided by end user’s hospitals, ambulatory care centers ACCs, home care, and other users each reflecting distinct drivers of demand and growth paths. Hospitals remain the largest and most established segment due to their crucial role in urgent care and complex patient treatment. Prominent tertiary and secondary hospitals in urban areas acquire advanced ventilators, oxygen systems, and detailed diagnostic tools, driven by high patient numbers and strict clinical needs. Hospitals also act as preferred sources for advanced monitoring equipment like capnographs and pulmonary function analyzers, facilitating both emergency care and managing chronic illnesses. Ambulatory Care Centers ACCs which include pulmonary rehabilitation facilities and specialized respiratory clinics have become more important as China alters its healthcare system. ACCs offer focused outpatient diagnostics and treatments for COPD, asthma, and sleep apnea, sparking the usage of portable equipment and point-of-care diagnostic tools. These centers increasingly utilize spirometry, oximetry, and sleep testing devices to manage substantial outpatient populations efficiently, supporting steady market growth. Home Care Settings are the quickest growing end-user category in China, propelled by an aging population, increasing chronic disease rates, and a preference for home-based management. Respiratory devices like portable oxygen concentrators, home ventilators, CPAP/BiPAP systems, and smart nebulizers are gaining popularity at home, backed by reimbursement policies and remote monitoring systems. The interest in home therapy options as patients aimed to avoid hospital visits while ensuring long-term respiratory assistance. Finally, other end users which include long-term care facilities, community health centers, and emergency medical services add to a niche but vital demand.

"Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031



Aspects covered in this report
• Respiratory Care Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Therapeutic Devices (Inhalers,Ventilators,Positive Airway Pressure (PAP) Devices,Humidifiers,Nebulizers,Others(Oxygen Concentrators, oxygen Hood))
• Monitoring Devices (Pulse Oximeters,Gas Analyzers,Others)
• Diagnostic Devices (Spirometers,Polysomnography Devices,Peak Flow Meters,Others)
• Consumables and Accessories (Disposable Resuscitators,Breathing Circuits,Masks,Tracheostomy Tubes,Others(Nasal Cannulas))
By Disease Indication
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other disease Indications (Respiratory Distress Syndrome, cystic Fibrosis)

By End User
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home care Settings
• Other End User
"